Why Kindred Biosciences, Inc. (KIN) stock is soaring today?
Shares of the Kindred Biosciences, Inc. (KIN) stock continuing the rising trend in pre-market today on June 16, 2021, following the announcement of the acquisition agreement between Kindred Biosciences and Elanco Animal Health Incorporated (NYSE: ELAN). The KIN stock price saw an uptrend of 48.58% to reach $9.42 a share at the time of this […]
What could be the reason behind Kindred Biosciences Inc (KIN) stock gains on Tuesday?
Kindred Biosciences Inc (KIN) stock had a good Tuesday. It gained 1.29% in the normal trading and further, it jumped 5.94% in the after-hours session on Tuesday, April 20, 2021. KIN shares have risen by 16.30% over the last 12 months, and they have lost 4.46% in the past week. Over the past three months, […]
Insider Selling Report: Kindred Biosciences Inc. [KIN]’s Dir, Bevers Denise, Sells 39,069 Shares
On Jan. 07, Bevers Denise divested U.S. $195,349 in shares of Kindred Biosciences Inc.. The Dir sold 39,069 shares at a price per share of $5.00. The transaction decreased this specific insider’s holdings to 143,835 shares worth around $0.72 million at present. Guggenheim took its Kindred Biosciences Inc. [KIN] rating to the equivalent of a […]
Kindred Biosciences, Inc. (KIN) Expanded Agreement with Vaxart To Gear Up Manufacturing Of COVID-19 and Other Vaccine Candidates
Kindred Biosciences, Inc. (KIN) this week came expanding an agreement with Vaxart, Inc. for the manufacturing of Vaxart’s oral vaccine for COVID-19 as well as other vaccine candidates. The biopharmaceutical company developing novel biologics will be performing manufacturing services through its wholly owned subsidiary Centaur Biopharmaceutical Services (Centaur), which is a provider of full service contract development […]
